Position in SCLX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,259
-$6,038 QoQ
Shares Held
1,090
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $714,031,909 across 12 Drug Manufacturers - General names. SCLX ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
221,464 | $203,695,943 | |
| 2 | JNJ |
Johnson & Johnson
|
563,045 | $137,630,719 | |
| 3 | ABBV |
AbbVie Inc.
|
493,002 | $107,223,004 | |
| 4 | MRK |
Merck & Co., Inc.
|
580,004 | $69,768,681 | |
| 5 | AMGN |
Amgen Inc
|
143,722 | $50,568,585 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
305,106 | $42,522,623 | |
| 7 | PFE |
Pfizer Inc
|
1,328,456 | $37,303,044 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
493,565 | $29,934,717 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,259 | 1,090 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $13,297 | 1,090 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $21,451 | 1,090 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,425 | 1,091 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||